It suggests that ES and mitochondrial damage caused by metabolic stress can also activate the cGAS-STING pathway, and targeting the cGAS-STING pathway has therapeutic potential for the treatment of metabolic diseases (Chung et al., 2019). This evidence concerns the gene STING1 and Other metabolic disease.